Group structure
7 companies in 5 countries
Loading your page…
Loading your page…
7 companies in 5 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 80
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Alfentanil-hameln 0,5 mg/ml oplossing voor injectieOplossing voor injectie | Alfentanil | Netherlands | Authorised | 2016 |
| Amiodaron HCl hameln 20 mg/ml, oplossing voor infusieOplossing voor infusie | Amiodarone | Netherlands | Authorised | 2021 |
| Amiodaron HCl hameln 50 mg/ml, concentraat voor oplossing voor injectie/infusieConcentraat voor oplossing voor injectie of infusie | Amiodarone | Netherlands | Authorised | 2018 |
| AMIODARONE HAMELNSoluzione per infusione | Amiodarone | Italy | Authorised | |
| Amiodaronklorid hameln 20 mg/ml otopina za infuzijuotopina za infuziju | Amiodarone | Croatia | Authorised | 2025 |
| Amiodaronklorid hameln 50 mg/ml koncentrat za otopinu za injekciju/infuzijuKoncentrat za otopinu za injekciju / infuziju | Amiodarone | Croatia | Marketed | 2022 |
| Atracurium-hameln 10 mg/ml, oplossing voor injectie/infusieOplossing voor injectie, Oplossing voor infusie | Atracurium | Netherlands | Authorised | 2002 |
| BESILATO DE ATRACURIO-HAMELN 10 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG10 mg · Solución inyectable | Atracurium | Spain | Authorised | 2002 |
| CEFAZOLINA HAMELNPolvere per soluzione iniettabile/per infusione | Cefazolin | Italy | Authorised | |
| Cefazoline hameln 1 g poeder voor oplossing voor injectie/infusiePoeder voor oplossing voor injectie of infusie | Cefazolin | Netherlands | Authorised | 2025 |
| Cefotaxim hameln 1 g poeder voor oplossing voor injectie/infusiePoeder voor oplossing voor injectie of infusie | Cefotaxime | Netherlands | Authorised | 2025 |
| Cefotaxim hameln 2 g poeder voor oplossing voor injectie/infusiePoeder voor oplossing voor injectie of infusie | Cefotaxime | Netherlands | Authorised | 2025 |
| CEFOTAXIMA HAMELNPolvere per soluzione iniettabile/per infusione | Cefotaxime | Italy | Authorised | |
| Ceftazidim hameln 1 g poeder voor oplossing voor injectie/infusiePoeder voor oplossing voor injectie of infusie | Ceftazidime | Netherlands | Authorised | 2025 |
| Ceftazidim hameln 2 g poeder voor oplossing voor injectie/infusiePoeder voor oplossing voor injectie of infusie | Ceftazidime | Netherlands | Authorised | 2025 |
| Ceftazidim hameln 500 mg poeder voor oplossing voor injectiePoeder voor oplossing voor injectie | Ceftazidime | Netherlands | Authorised | 2025 |
| CEFTAZIDIMA HAMELNPolvere per soluzione iniettabile/per infusione | Ceftazidime | Italy | Authorised | |
| Ceftriaxon hameln 1 g poeder voor oplossing voor injectie/infusiePoeder voor oplossing voor injectie of infusie | Ceftriaxone | Netherlands | Authorised | 2025 |
| Ceftriaxon hameln 2 g poeder voor oplossing voor injectie/infusiePoeder voor oplossing voor injectie of infusie | Ceftriaxone | Netherlands | Authorised | 2025 |
| CEFTRIAXONE HAMELNPolvere per soluzione iniettabile/per infusione | Ceftriaxone | Italy | Authorised | |
| Ciprofloxacin-hameln 2 mg/ml, oplossing voor infusieOplossing voor infusie | Ciprofloxacin | Netherlands | Authorised | 2010 |
| Clindamycine hameln 150 mg/ml oplossing voor injectie/infusieOplossing voor injectie, Oplossing voor infusie | Clindamycin | Netherlands | Authorised | 2023 |
| DAPTOMICINA HAMELNPolvere per soluzione iniettabile/per infusione | Daptomycin | Italy | Authorised | |
| Deksametazon hameln 4 mg/ml otopina za injekcijuotopina za injekciju | Dexamethasone | Croatia | Marketed | 2026 |
| DESAMETASONE HAMELNSoluzione iniettabile | Desametasone | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 36 | 36 | 0 | CompaniesAll medicines |
| Croatia | 19 | 19 | 0 | CompaniesAll medicines |
| Italy | 14 | 14 | 0 | CompaniesAll medicines |
| Saudi Arabia | 6 | 6 | 0 | CompaniesAll medicines |
| Romania | 2 | 0 | 2 | CompaniesAll medicines |
| United States | 2 | 2 | 0 | CompaniesAll medicines |
| Spain | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Serbia, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Register právnických osôb, podnikateľov a orgánov verejnej moci; public API licence names Štatistický úrad Slovenskej republiky; administration transferred to Ministerstvo vnútra SR; original API URL, literal identifier and source locators, source version and retrieval date; https://creativecommons.org/licenses/by/4.0/; normalization identified.
Licence: Creative Commons Attribution
Slovak Ministry of Finance, Register účtovných závierok (RÚZ) Open API; exact IČO/accounting-unit, filing, report and template IDs; original API URLs, source locators and retrieval dates; https://www.registeruz.sk/cruz-public/home/api; extraction/normalization stated.
Licence: CC0